Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsLeukocytes, MononuclearMyeloablative AgonistsGraft vs Host DiseaseBusulfanTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsHematopoiesisCytarabineHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationNeoplasmsTransplantation ChimeraRetrospective StudiesTime FactorsTissue DonorsSurvival RateWhole-Body IrradiationSurvival AnalysisInfectionLymphoma, T-CellDoxorubicinPlatelet CountHistocompatibilityPOEMS SyndromeImmunosuppressive AgentsRecombinant ProteinsHistocompatibility TestingT-LymphocytesPrednisoneBlood CellsCarboplatinLeukemia, Myeloid, AcuteDexamethasoneBlood Cell CountFollow-Up StudiesTransplantation, IsogeneicLeukemiaVidarabineAntineoplastic AgentsProspective StudiesCells, CulturedLymphomaImmunophenotypingFlow CytometryCytomegalovirus InfectionsBone Marrow PurgingFeasibility StudiesFatal OutcomeGraft vs Leukemia EffectLymphocytesClinical Trials as TopicLymphocyte ActivationAnemia, AplasticMyelodysplastic SyndromesAntigens, CDCell SeparationLymphocyte DepletionBone MarrowLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationBlood Transfusion, AutologousHLA AntigensBlood DonorsLeukocyte CountPrognosisMonocytesCyclosporine